"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study

M Vervloet, V Bencova, F Malberti, N Ashman, I Os, H Saha, P Ureña, E Zitt, M Rix, M Ryba, D Fouque, B Dehmel, F Petavy, Stephen Jacobson

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

16 Citationer (Scopus)

Abstract

The pan-European ECHO observational study evaluated cinacalcet in adult dialysis patients with secondary hyperparathyroidism (SHPT) in "real-world" clinical practice. A sub-analysis compared data for 7 European countries/country clusters: Austria, CEE (Czech Republic and Slovakia), France, Italy, Netherlands, Nordics (Denmark, Finland, Norway, and Sweden), and the UK/Ireland.
OriginalsprogEngelsk
TidsskriftClinical Nephrology
Vol/bind74
Udgave nummer3
Sider (fra-til)198-208
Antal sider11
ISSN0301-0430
StatusUdgivet - 1 sep. 2010

Citationsformater